Skip to main navigation
Skip to search
Skip to main content
Edge Hill University Home
Help & FAQ
Link opens in a new tab
Search content at Edge Hill University
Home
Profiles
Research units
Research output
Projects
Student theses
Activities
Prizes
Impacts
Equipment
Datasets
Dual antibiotics for bronchiectasis
Lambert Felix
, Seamus Grundy
, Stephen J. Milan
, Ross Armstrong
, Haley Harrison
, Dave Lynes
, Sally Spencer
Sport & Physical Activity
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Link opens in a new tab
Citations (Scopus)
114
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dual antibiotics for bronchiectasis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Odds Ratio
100%
Confidence Interval
100%
Adverse Event
100%
Bronchiectasis
100%
Antibiotic Resistance
83%
Infection
50%
Quality of Life
50%
Lung Volume
33%
Ciprofloxacin
33%
Efficacy
33%
Exercise
33%
Antimicrobial Agent
33%
Film
16%
Cochrane Library
16%
Clinical Outcome
16%
Combination Therapy
16%
CINAHL
16%
Wheezing
16%
Antibiotic Therapy
16%
Dilatation
16%
Chronic Respiratory Tract Disease
16%
Computer Assisted Tomography
16%
Thorax Radiography
16%
PsycINFO
16%
Embase
16%
Recurrence Risk
16%
Bacterial Load
16%
Mortality Rate
16%
National Health Organization
16%
Monotherapy
16%
Data Synthesis
16%
Bronchography
16%
Gentamicin
16%
Tobramycin
16%
Economic and Social Development
16%
Clinical Trial
16%
Accident Prevention
16%
Medicine and Dentistry
Bronchiectasis
100%
Antibiotics
100%
Adverse Event
66%
Odds Ratio
66%
Oral
66%
Antibiotic Resistance
55%
Infection
33%
Quality of Life
33%
Sputum
33%
Lung
33%
Exercise
22%
Ciprofloxacin
22%
Antimicrobial Agent
22%
Randomized Controlled Trial
11%
Clinical Trial
11%
Wheeze
11%
Antibiotic Therapy
11%
Thorax Radiography
11%
High-Resolution Computed Tomography
11%
Bronchography
11%
Chronic Respiratory Tract Disease
11%
Combination Therapy
11%
Pseudomonas aeruginosa
11%
Monotherapy
11%
Complementary Medicine
11%
Recurrence Risk
11%
Mortality Rate
11%
Tobramycin
11%
Gentamicin
11%
Bacterium
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
100%
Bronchiectasis
100%
Adverse Event
66%
Antibiotic Resistance
55%
Infection
33%
Ciprofloxacin
22%
Antimicrobial Agent
22%
Randomized Controlled Trial
11%
Antibiotic Therapy
11%
Clinical Trial
11%
Chronic Respiratory Tract Disease
11%
Pseudomonas aeruginosa
11%
Gentamicin
11%
Recurrence Risk
11%
Mortality Rate
11%
Wheezing
11%
Combination Therapy
11%
Monotherapy
11%
Tobramycin
11%
Bacterium
11%
Keyphrases
Triple Antibiotic Paste
100%
Dual Therapy
66%
Treatment Benefit
50%
Systemic Markers
33%
Clinical Response Rate
16%
Oral Ciprofloxacin
16%
Microbiological Response
16%
World Health Organization International Clinical Trials Registry Platform
16%